Weight Variation During Chemotherapy in Breast Cancer Patients

July 23, 2015 updated by: Centre Jean Perrin

Weight Variation and Mechanisms Involved, During Chemotherapy in Breast Cancer Patients

Weight variation has been reported as a side effect of chemotherapy treatment in early breast cancer patients. To date, there is growing evidence for an increased risk of relapse and death in these patients who gain or lose weight. However, causes of weight variation during chemotherapy and mechanisms involved in the poor prognosis have been little studied.

Thus, the investigators are conducting a prospective study to characterize weight variation in terms of body composition and to identify the mechanisms involved.

Study Overview

Status

Completed

Conditions

Study Type

Interventional

Enrollment (Actual)

52

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Clermont-Ferrand, France, 63000
        • Centre Jean Perrin

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

No older than 70 years (Child, Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • menopausal women
  • breast cancer
  • patients requiring chemotherapy treatment
  • WHO performance status 0-2

Exclusion Criteria:

  • diabetics
  • patients with metastases
  • other cancer

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: additional examinations/measurements
blood test (hormonal, inflammatory, lipid and growth factors); body composition measurements; energy balance evaluation

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Change from baseline in body composition
Time Frame: within 2 weeks before chemotherapy; 1month after the last chemotherapy; and 6 months later.
within 2 weeks before chemotherapy; 1month after the last chemotherapy; and 6 months later.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from baseline in energy balance
Time Frame: within 2 weeks before chemotherapy; 1month after the last chemotherapy; and 6 months later.
resting energy expenditure, physical activity, food records.
within 2 weeks before chemotherapy; 1month after the last chemotherapy; and 6 months later.
Change from baseline in muscle strength
Time Frame: within 2 weeks before chemotherapy; 1month after the last chemotherapy; and 6 months later.
within 2 weeks before chemotherapy; 1month after the last chemotherapy; and 6 months later.
Change from baseline in biological factors (hormonal, inflammatory, lipid, growth factors)
Time Frame: within 2 weeks before chemotherapy; 1month after the last chemotherapy; and 6 months later.
within 2 weeks before chemotherapy; 1month after the last chemotherapy; and 6 months later.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Xavier DURANDO, MD, PhD, Centre Jean Perrin

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

September 1, 2011

Primary Completion (Actual)

March 1, 2013

Study Completion (Actual)

January 1, 2014

Study Registration Dates

First Submitted

January 3, 2012

First Submitted That Met QC Criteria

January 5, 2012

First Posted (Estimate)

January 10, 2012

Study Record Updates

Last Update Posted (Estimate)

July 24, 2015

Last Update Submitted That Met QC Criteria

July 23, 2015

Last Verified

July 1, 2015

More Information

Terms related to this study

Other Study ID Numbers

  • 2011-A00206-35

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Breast Cancer

Clinical Trials on blood test/ additional measurement

3
Subscribe